Eight Roads Investments - Net Worth and Insider Trading
Eight Roads Investments Net Worth
The estimated net worth of Eight Roads Investments is at least $2.2 Billion dollars as of 2024-06-23. Eight Roads Investments is the 2101 Beneficial owner of Innovent Biologics Inc and owns about 60,037,329 shares of Innovent Biologics Inc (HKSE:01801) stock worth over $2.2 Billion. Details can be seen in Eight Roads Investments's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eight Roads Investments has not made any transactions after 2019-05-24 and currently still holds the listed stock(s).
Transaction Summary of Eight Roads Investments
Eight Roads Investments Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eight Roads Investments owns 1 companies in total, including Innovent Biologics Inc (HKSE:01801) .
Click here to see the complete history of Eight Roads Investments’s form 4 insider trades.
Insider Ownership Summary of Eight Roads Investments
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01801 | Innovent Biologics Inc | 2019-05-24 | 2101 Beneficial owner |
Eight Roads Investments Latest Holdings Summary
Eight Roads Investments currently owns a total of 1 stock. Eight Roads Investments owns 60,037,329 shares of Innovent Biologics Inc (HKSE:01801) as of May 24, 2019, with a value of $2.2 Billion.
Latest Holdings of Eight Roads Investments
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01801 | Innovent Biologics Inc | 2019-05-24 | 60,037,329 | 36.80 | 2,209,373,707 |
Holding Weightings of Eight Roads Investments
Eight Roads Investments Form 4 Trading Tracker
According to the SEC Form 4 filings, Eight Roads Investments has made a total of 0 transactions in Innovent Biologics Inc (HKSE:01801) over the past 5 years. The most-recent trade in Innovent Biologics Inc is the sale of 10,620,000 shares on May 24, 2019, which brought Eight Roads Investments around $0.
Insider Trading History of Eight Roads Investments
- 1
Eight Roads Investments Trading Performance
Eight Roads Investments Ownership Network
Eight Roads Investments Owned Company Details
What does Innovent Biologics Inc do?
Who are the key executives at Innovent Biologics Inc?
Eight Roads Investments is the 2101 Beneficial owner of Innovent Biologics Inc. Other key executives at Innovent Biologics Inc include 2502 Approved lending agent JPMorgan Chase & Co. , 2101 Beneficial owner Yu De-chao Michael , and Temasek Holdings (private) Limited .
Innovent Biologics Inc (HKSE:01801) Insider Trades Summary
Over the past 18 months, Eight Roads Investments made no insider transaction in Innovent Biologics Inc (HKSE:01801). Other recent insider transactions involving Innovent Biologics Inc (HKSE:01801) include a net sale of 0 shares made by Morgan Stanley , a net sale of 1,409,211 shares made by Yu De-chao Michael , and a net purchase of 485,276 shares made by The Capital Group Companies, Inc. .
In summary, during the past 3 months, insiders sold 906,250 shares of Innovent Biologics Inc (HKSE:01801) in total and bought 0 shares, with a net sale of 906,250 shares. During the past 18 months, 10,222,711 shares of Innovent Biologics Inc (HKSE:01801) were sold and 9,565,276 shares were bought by its insiders, resulting in a net sale of 657,435 shares.
Innovent Biologics Inc (HKSE:01801)'s detailed insider trading history can be found in Insider Trading Tracker table.
Innovent Biologics Inc Insider Transactions
Eight Roads Investments Mailing Address
Above is the net worth, insider trading, and ownership report for Eight Roads Investments. Currently GuruFocus does not have mailing address information for Eight Roads Investments.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
